Trial · NCT07891559
Trauma Suppression Training for Veterans
NCT07891559, Not applicable, Completed, Palo Alto Veterans Institute for Research
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Trauma Suppression Training for Veterans. Trials, record NCT07891559. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07891559
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Trauma Suppression Training for Veterans
- NCT number
- NCT07891559
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 11 participants, actual
- Lead sponsor
- Palo Alto Veterans Institute for Research
- Conditions
- Posttraumatic Stress Disorder (PTSD)
- Interventions
- Web-based Think/No-Think retrieval-suppression training
- First posted
- 2026-10-23
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Recruitment | Recruitment period (November 2025 to July 2026) | Number of eligible veterans enrolled (consented) during the recruitment period, against the target of 20 completers. |
| Primary | Retention | From consent through Training Day 3 (about 5 days) | Percentage of consented participants who complete all study sessions. |
| Primary | Protocol adherence | Training Days 1 to 3 | Percentage of participants who begin training and complete all three training days. |
| Primary | Number of participants rating the suppression strategy as useful outside the laboratory | End of Training Day 3 | Single post-training yes/no item: "Do you think that the suppression strategy you learned through the course of this training is useful or helpful to use outside the lab in your own life?" Reported as the number and percentage of participants answering Yes; a higher percentage indicates greater acceptability. |
| Primary | Number of completers whose training was delivered on the protocol-specified schedule | From stimulus preparation through Training Day 3 (about 5 days) | Delivery was recorded as per protocol when stimulus preparation was followed by three training days on consecutive days, as specified in the protocol. Reported as the number and percentage of completers; a higher percentage indicates greater fidelity of delivery. |
| Primary | Adverse events | From consent through Training Day 3 | Number of participants with serious adverse events. |
| Primary | Number of participants likely to re-use the suppression strategy, assessed by a 5-point rating item | End of Training Day 3 | Single post-training item: "How likely are you to re-use the suppression strategy you learned to decrease your anxiety or thoughts about the negative events in your life?" Rated from 1 (Very unlikely) to 5 (Very likely); minimum 1, maximum 5; higher scores indicate greater likelihood of re-use (a better outcome). Reported as the number and percentage of participants rating Likely (4) or Very likely (5). |
| Primary | Self-rated effectiveness at stopping thoughts about upsetting events, assessed by a 5-point rating item | End of Training Day 3 | Participants rated how effectively they could stop thoughts about their upsetting events at the beginning of training (Training Day 1, rated retrospectively) and at the end of training (Training Day 3). Each rating ranges from 1 (Not at all effective) to 5 (Extremely effective); higher scores indicate better self-rated effectiveness (a better outcome). |
| Primary | Number of completers confirming the suppression-strategy instruction they were assigned, assessed by a post-training yes/no item | Training Day 3 | After training, participants were shown the strategy instruction for their assigned condition and asked to confirm (Yes/No) that it was the strategy they had practiced. Reported as the number and percentage answering Yes; a higher percentage indicates more accurate delivery of the assigned instruction. |
| Secondary | Warwick-Edinburgh Mental Well-being Scale (WEMWBS) | Baseline (introductory session) and end of Training Day 3 (about 5 days) | Change in total score (range 14 to 70; higher scores indicate better well-being). |
1 to 10 of 19Source ClinicalTrials.gov
See all 19 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 37729415 | BACKGROUND |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07891559
GET https://conductscience.org/api/trials/v1/NCT07891559/registered